Evidence map›Paper›PMID 34249875›Full record

ReviewFrontiers in chemistry2021

Photocatalytic Oxidation Reactions Mediated by Covalent Organic Frameworks and Related Extended Organic Materials.

José Alemán, Rubén Mas-Ballesté

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Red-Light-Driven C(spJournal of the American Chemical Society · 2025
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

José AlemánDepartment of Organic Chemistry (Module 1), Facultad de Ciencias, Universidad Autónoma de Madrid, Madrid, Spain.
Rubén Mas-BallestéInstitute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, Madrid, Spain.
Universidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covalent Organic Frameworks (COFs) and related extended organic materials have been widely used as photocatalysts in the last few years. Such interest arises from the wide range of covalent linkages employed in their construction, which offer many possibilities to design extended frameworks and to link photoactive building blocks. Thus, the potential utility of predesigned organic photoactive fragments can be synergistically added to the inherent advantages of heterogeneous catalysis, such as recyclability and easy separation of catalyst. In this overview, the current state of the art on the design of organic materials for photocatalytic oxidation reactions will be presented. The designing process of these materials is usually conditioned by the generally accepted concept that crystallinity and porosity defines the quality of the heterogeneous catalysts obtained. The care for the structural integrity of materials obtained is understandable because many properties and applications are intimately related to these features. However, the catalytic activity does not always directly depends on these characteristics. A critical compilation of the available literature is performed in order to offer a general perspective of the use of COFs and Covalent Triazine Frameworks (CTFs) in photocatalytic oxidation processes, including water oxidation, which constitute an important outcome relevant to artificial photosynthesis.

Indexed as

covalent organic frameworksoxidationoxygen evolution reactionphotocatalysissynthesis

Identifiers

PMID34249875
PMCPMC8263918
OpenAlexW3173463748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.